Literature DB >> 20505322

Role for catecholamines in tumor progression: possible use for β-blockers in the treatment of cancer.

Eric V Yang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20505322      PMCID： PMC3040831          DOI： 10.4161/cbt.10.1.12260

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN： 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  19 in total

1.  Antihypertensive drug use and the risk of prostate cancer (Canada).

Authors:  Linda Perron; Isabelle Bairati; François Harel; François Meyer
Journal:  Cancer Causes Control       Date:  2004-08       Impact factor: 2.506

2.  Stress hormone-mediated invasion of ovarian cancer cells.

Authors:  Anil K Sood; Robert Bhatty; Aparna A Kamat; Charles N Landen; Liz Han; Premal H Thaker; Yang Li; David M Gershenson; Susan Lutgendorf; Steven W Cole
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

3.  Adrenal metastasis from renal cell carcinoma: significance of adrenalectomy.

Authors:  Akihiro Ito; Makoto Satoh; Chikara Ohyama; Seiichi Saito; Ichiro Shintaku; Osamu Nakano; Hiroshi Aoki; Senji Hoshi; Seiichi Orikasa
Journal:  Int J Urol       Date:  2002-03       Impact factor: 3.369

4.  The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers.

Authors:  Daniel Palm; Kerstin Lang; Bernd Niggemann; Theodore L Drell; Kai Masur; Kurt S Zaenker; Frank Entschladen
Journal:  Int J Cancer       Date:  2006-06-01       Impact factor: 7.396

5.  Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.

Authors:  Premal H Thaker; Liz Y Han; Aparna A Kamat; Jesusa M Arevalo; Rie Takahashi; Chunhua Lu; Nicholas B Jennings; Guillermo Armaiz-Pena; James A Bankson; Murali Ravoori; William M Merritt; Yvonne G Lin; Lingegowda S Mangala; Tae Jin Kim; Robert L Coleman; Charles N Landen; Yang Li; Edward Felix; Angela M Sanguino; Robert A Newman; Mary Lloyd; David M Gershenson; Vikas Kundra; Gabriel Lopez-Berestein; Susan K Lutgendorf; Steven W Cole; Anil K Sood
Journal:  Nat Med       Date:  2006-07-23       Impact factor: 53.440

6.  Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells.

Authors:  Eric V Yang; Anil K Sood; Min Chen; Yang Li; Tim D Eubank; Clay B Marsh; Scott Jewell; Nicholas A Flavahan; Carl Morrison; Peir-En Yeh; Stanley Lemeshow; Ronald Glaser
Journal:  Cancer Res       Date:  2006-11-01       Impact factor: 12.701

7.  Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma.

Authors:  Leo J Schouten; Joost Rutten; Hans A M Huveneers; Albert Twijnstra
Journal:  Cancer       Date:  2002-05-15       Impact factor: 6.860

8.  Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines.

Authors:  Susan K Lutgendorf; Steven Cole; Erin Costanzo; Sarah Bradley; Jeremy Coffin; Sarvenaz Jabbari; Kaitlin Rainwater; Justine M Ritchie; Maria Yang; Anil K Sood
Journal:  Clin Cancer Res       Date:  2003-10-01       Impact factor: 12.531

9.  Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells.

Authors:  T L Drell; J Joseph; K Lang; B Niggemann; K S Zaenker; F Entschladen
Journal:  Breast Cancer Res Treat       Date:  2003-07       Impact factor: 4.872

Review 10.  Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters.

Authors:  Frank Entschladen; Theodore L Drell; Kerstin Lang; Jan Joseph; Kurt S Zaenker
Journal:  Lancet Oncol       Date:  2004-04       Impact factor: 41.316
View more
  4 in total

1.  Systems pharmacogenomics - gene, disease, drug and placebo interactions: a case study in COMT.

Authors:  Kathryn T Hall; Joseph Loscalzo; Ted J Kaptchuk
Journal:  Pharmacogenomics       Date:  2019-05       Impact factor: 2.533

2.  Vascular tone and angiogenesis modulation by catecholamine coordinated to ruthenium.

Authors:  Jacqueline Querino Alves; Laena Pernomian; Cássia Dias Silva; Mayara Santos Gomes; Ana Maria de Oliveira; Roberto Santana da Silva
Journal:  RSC Med Chem       Date:  2020-02-27

Review 3.  Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward.

Authors:  Maria Rain Jennings; David Munn; John Blazeck
Journal:  J Immunother Cancer       Date:  2021-10       Impact factor: 13.751

Review 4.  Neuroendocrine Factors in Melanoma Pathogenesis.

Authors:  Cristian Scheau; Carmen Draghici; Mihaela Adriana Ilie; Mihai Lupu; Iulia Solomon; Mircea Tampa; Simona Roxana Georgescu; Ana Caruntu; Carolina Constantin; Monica Neagu; Constantin Caruntu
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.